Management of Hypertension During Propofol Administration

Understanding Propofol's Cardiovascular Effects

Propofol typically causes decreases in cardiac output, systemic vascular resistance, and arterial pressure, making hypotension the more common hemodynamic concern, according to the American Gastroenterological Association 1, 2
The cardiovascular effects of propofol include negative cardiac inotropy and respiratory depression, which usually respond rapidly to dose reduction or interruption of drug infusion, as stated by the American Gastroenterological Association 1

Administer intravenous propofol in small, incremental doses or by infusion, titrating to the desired endpoints, as recommended by the American Society of Anesthesiologists (ASA) 3
Allow sufficient time between doses so the peak effect of each dose can be assessed before subsequent administration, according to the American Society of Anesthesiologists (ASA) 3

Consider combination propofol regimens that allow for lower propofol doses while maintaining adequate sedation, as suggested by the American Gastroenterological Association 6
When propofol is combined with small doses of an opioid analgesic and a benzodiazepine, analgesia and amnesia can be achieved with subhypnotic doses of propofol, reducing the risk of hemodynamic instability, according to the American Gastroenterological Association 6
Be aware that co-administration of other central nervous system medications such as opioids and barbiturates potentiate the sedative effect of propofol and may enhance its hemodynamic effects, as noted by the American Gastroenterological Association and the American Society of Anesthesiologists (ASA) 1, 3

Continuous monitoring of heart rate, blood pressure, and pulse oximetry is essential during propofol administration, as recommended by the American Gastroenterological Association 5
For deeper sedation or general anesthesia, consider more advanced monitoring including electrocardiography, according to the American Gastroenterological Association 5

Be aware that the pharmacokinetic parameters of propofol are altered by various factors including weight, sex, age, and concomitant disease, as stated by the American Gastroenterological Association 2